A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm

被引：55

作者：

Tak, Paul P. ^{[1
]}

机构：

[1] Univ Amsterdam, Div Clin Immunol & Rheumatol, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands

来源：

RHEUMATOLOGY | 2012年 / 51卷 / 04期

关键词：

rheumatoid arthritis; treatment; biomarkers; biologicals; TUMOR-NECROSIS-FACTOR; SYNOVIAL CELL INFILTRATE; FACTOR-ALPHA THERAPY; CITRULLINATED PROTEIN ANTIBODIES; I INTERFERON SIGNATURE; PERIPHERAL-BLOOD CELLS; DOUBLE-BLIND; CLINICAL-RESPONSE; MONOCLONAL-ANTIBODY; DISEASE-ACTIVITY;

D O I：

10.1093/rheumatology/ker300

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

RA is a syndrome consisting of different pathogenetic subsets in which distinct molecular mechanisms may drive common final pathways. Recent work has provided proof of principle that biomarkers may be identified predictive of the response to targeted therapy. Based on new insights, an initial treatment algorithm is presented that may be used to guide treatment decisions in patients who have failed one TNF inhibitor. Key questions in this algorithm relate to the question whether the patient is a primary vs a secondary non-responder to TNF blockade and whether the patient is RF and/or anti-citrullinated peptide antibody positive. This preliminary algorithm may contribute to more cost-effective treatment of RA, and provides the basis for more extensive algorithms when additional data become available.

引用

页码：600 / 609

页数：10

共 88 条

[1] Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis [J].

Badot, Valerie ;

Galant, Christine ;

Toukap, Adrien Nzeusseu ;

Theate, Ivan ;

Maudoux, Anne-Lise ;

Van den Eynde, Benoit J. ;

Durez, Patrick ;

Houssiau, Frederic A. ;

Lauwerys, Bernard R. .

ARTHRITIS RESEARCH & THERAPY, 2009, 11 (02)

[2] Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study [J].

Bartelds, G. M. ;

Wijbrandts, C. A. ;

Nurmohamed, M. T. ;

Stapel, S. ;

Lems, W. F. ;

Aarden, L. ;

Dijkmans, B. A. C. ;

Tak, P. P. ;

Wolbink, G. J. .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (05) :817-821

[3] Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up [J].

Bartelds, Geertje M. ;

Krieckaert, Charlotte L. M. ;

Nurmohamed, Michael T. ;

van Schouwenburg, Pauline A. ;

Lems, Willem F. ;

Twisk, Jos W. R. ;

Dijkmans, A. C. ;

Aarden, Lucien ;

Wolbink, Gerrit Jan .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (14) :1460-1468

[4] Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset [J].

Berglin, E ;

Johansson, T ;

Sundin, U ;

Jidell, E ;

Wadell, G ;

Hallmans, G ;

Rantapää-Dahlqvist, S .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (04) :453-458

[5] Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice [J].

Bombardieri, S. ;

Ruiz, A. A. ;

Fardellone, P. ;

Geusens, P. ;

McKenna, F. ;

Unnebrink, K. ;

Oezer, U. ;

Kary, S. ;

Kupper, H. ;

Burmester, G. R. .

RHEUMATOLOGY, 2007, 46 (07) :1191-1199

[6]

Braun-Moscovici Y, 2006, J RHEUMATOL, V33, P497

[7] Synovial Tissue Sublining CD68 Expression Is a Biomarker of Therapeutic Response in Rheumatoid Arthritis Clinical Trials: Consistency Across Centers [J].

Bresnihan, Barry ;

Pontifex, Eliza ;

Thurlings, Rogier M. ;

Vinkenoog, Marjolein ;

El-Gabalawy, Hani ;

Fearon, Ursula ;

Fitzgerald, Oliver ;

Gerlag, Danielle M. ;

Rooney, Terence ;

van de Sande, Marleen G. ;

Veale, Douglas ;

Vos, Koen ;

Tak, Paul-Peter .

JOURNAL OF RHEUMATOLOGY, 2009, 36 (08) :1800-1802

[8] Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis [J].

Buch, Maya H. ;

Smolen, Josef S. ;

Betteridge, Neil ;

Breedveld, Ferdinand C. ;

Burmester, Gerd ;

Doerner, Thomas ;

Ferraccioli, Gianfranco ;

Gottenberg, Jacques-Eric ;

Isaacs, John ;

Kvien, Tore K. ;

Mariette, Xavier ;

Martin-Mola, Emilio ;

Pavelka, Karel ;

Tak, Paul P. ;

van der Heijde, Desiree ;

van Vollenhoven, Ronald F. ;

Emery, Paul .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) :909-920

[9] Switching TNF-alpha antagonists in rheumatoid arthritis: The experience of the LORHEN registry [J].

Caporali, Roberto ;

Sarzi-Puttini, Piercarlo ;

Atzeni, Fabiola ;

Gorla, Roberto ;

Filippini, Matteo ;

Marchesoni, Antonio ;

Favalli, Ennio Giulio ;

Bobbio-Pallavicini, Francesca ;

Montecucco, Carlomaurizio .

AUTOIMMUNITY REVIEWS, 2010, 9 (06) :465-469

[10] Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries [J].

Chatzidionysiou, Katerina ;

Lie, Elisabeth ;

Nasonov, Evgeny ;

Lukina, Galina ;

Hetland, Merete Lund ;

Tarp, Ulrik ;

Gabay, Cem ;

van Riel, Piet L. C. M. ;

Nordstrom, Dan C. ;

Gomez-Reino, Juan ;

Pavelka, Karel ;

Tomsic, Matija ;

Kvien, Tore K. ;

van Vollenhoven, Ronald F. .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (09) :1575-1580

← 1 2 3 4 5 6 7 8 9 →